Conference Calendar - ESMO Breast Cancer Virtual Meeting 2020

Conference Calendar

Everything

Everything
Session Title
Session Number
Presentation Title
Presentation Number
Presenter
Author
Chair

Filter By

Day

Select AllDeselect All
23.05.202026
24.05.202024

Select AllDeselect All
Channel 112
Channel 29
Channel 39
ePosters2
Industry satellites (On Demand)18

Select AllDeselect All
Educational session19
ePoster2
Industry Satellite Symposia18
Keynote2
Mini oral1
Opening/closure2
Proffered paper3
Special session2
Young oncologist session1

Presentation Type

Select AllDeselect All
Abstract7
Invited speaker33
Late-Breaking Abstract1
Satellite Speaker18
Trial in Progress2

Presentation Topic

Select AllDeselect All
Biomarkers and translational research and precision medicine3
Breast cancer48
Early Breast cancer: Adjuvant therapy3
Early Breast cancer: Neoadjuvant therapy4
Early Breast cancer: Surgery and radiotherapy2
Immunotherapy3
Metastatic Breast cancer5
Supportive care and survivorship4

Advanced Search

Sign in

Home
Calendar View
Final Programme (PDF)
All Presentations
All Sessions

Displaying One Session

View

List
Calendar

CME Webinar Supported by Daiichi Sankyo - Industry Satellite Symposium: Novel Therapies for Relapsed or Refractory HER2- Positive Metastatic Breast Cancer

Novel Anti-HER2-Directed ADCs

Presenter

Adam M. Brufsky (Pittsburgh, PA, United States of America)

Novel Targeted Therapies for MBC - Tyrosine kinase inhibitors

Presenter

Cristina Saura Manich (Barcelona, Spain)

Novel Anti-HER2 Monoclonal Antibody

Presenter

Thomas Bachelot (Lyon, France)

Case Discussion: Medical Need for Novel HER2-Directed Options After Failure on Standard-of-Care Treatments

Presenter

Thomas Bachelot (Lyon, France)

Please use one of the following browsers to view the website: Microsoft Edge, Google Chrome, Safari, Firefox.
Internet Explorer is no longer a Microsoft supported browser.

For technical support please contact breast@support.ctimeetingtech.com
© 2020 cSLIDE CTI MEETING TECHNOLOGY. All rights reserved.